Showing results (551-560 of 921) with videos related to

Sort By:
Pageof 93
Circulatory Shock|February 1, 1992
Pentafraction reduces the lung lymph response after endotoxin administration in the ovine modelL D Traber, B A Brazeal, M Schmitz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapyM Schmitz, G M Michl, R Walli, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 3, 2013
Cystic fibrosis in adults: short-term and long-term reproducibility of the Brody score for lung morphology in low-dose MDCT scansK Weber, M Paolini, M Schmitz, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patientsH T Greinix, W Linkesch, M Seifert, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2012
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancerRupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, et al.
Breast Cancer Research and Treatment|January 2, 2004
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Anti-Cancer Drugs|January 19, 2005
Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experienceWolfgang J Köstler, Günther G Steger, Michael Krainer, et al.
Breast (Edinburgh, Scotland)|July 15, 2014
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patientsAnna S Berghoff, Rupert Bartsch, Matthias Preusser, et al.
British Journal of Cancer|July 23, 2013
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trialM Gnant, G Pfeiler, H Stöger, et al.
Pageof 93